Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|May 29, 2020
Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic ControlJennifer Andres, Michael Barros, Michael Arutunian, et al.Diabetes & Metabolic Syndrome|November 2, 2025
Compounded incretins in clinical practice: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical PharmacyLindsay A Courtney, Jennifer N Clements, Diana Isaacs, et al.Journal of Pharmacy Practice|March 30, 2018
Pharmacists' Impact on Secondary Stroke PreventionJennifer Andres, Olivia Stanton-Ameisen, Sara Walton, et al.Current Medical Research and Opinion|August 20, 2015
Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical PharmacyJennifer N Clements, Heather P Whitley, Jennifer J D'Souza, et al.Innovations in Pharmacy|May 19, 2021
Influential Factors of Successful Hepatitis C Treatment in Elderly PatientsJennifer Andres, Mandee Noval, Christine Mauriello, et al.Expert Review of Endocrinology & Metabolism|March 8, 2023
Significant publications in diabetes pharmacotherapy and technology in 2020Jennifer N Clements, Rachel Franks, Diana Isaacs, et al.Methods in Molecular Biology (Clifton, N.J.)|May 24, 2021
A Protoplast-Based Bioassay to Quantify Strigolactone Activity in Arabidopsis Using StrigoQuantJustine Braguy, Sophia L Samodelov, Jennifer Andres, et al.Advanced Biology|May 24, 2021
Blue Light-Operated CRISPR/Cas13b-Mediated mRNA Knockdown (Lockdown)Tim Blomeier, Patrick Fischbach, Leonie-Alexa Koch, et al.Integrated Healthcare Journal|July 13, 2023
Interdisciplinary patient-centred poststroke care in Follow-up After Stroke, Screening and Treatment (FASST) clinic model: a proof-of-concept pilot studyMin Sun Kim, Sean V Cleymaet, Seung Kim, et al.American Journal of Clinical Dermatology|September 13, 2021
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital WartsScott Guenthner, Wendy McFalda, Melita Tate, et al.Pageof 6